RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gongwin Biopharm Holdings Co Stock

Gongwin Biopharm Holdings Co ROE 2024

Gongwin Biopharm Holdings Co ROE

-0.07

Ticker

6617.TWO

ISIN

KYG409471060

In 2024, Gongwin Biopharm Holdings Co's return on equity (ROE) was -0.07, a -61.69% increase from the -0.18 ROE in the previous year.

Gongwin Biopharm Holdings Co Aktienanalyse

What does Gongwin Biopharm Holdings Co do?

Gongwin Biopharm Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Gongwin Biopharm Holdings Co's Return on Equity (ROE)

Gongwin Biopharm Holdings Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Gongwin Biopharm Holdings Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Gongwin Biopharm Holdings Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Gongwin Biopharm Holdings Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Gongwin Biopharm Holdings Co stock

What is the ROE (Return on Equity) of Gongwin Biopharm Holdings Co this year?

The ROE of Gongwin Biopharm Holdings Co this year is -0.07 undefined.

How has the Return on Equity (ROE) of Gongwin Biopharm Holdings Co developed compared to the previous year?

The ROE of Gongwin Biopharm Holdings Co has increased by -61.69% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Gongwin Biopharm Holdings Co?

A high ROE indicates that Gongwin Biopharm Holdings Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Gongwin Biopharm Holdings Co?

A low ROE can indicate that Gongwin Biopharm Holdings Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Gongwin Biopharm Holdings Co affect the company?

A change in ROE (Return on Equity) of Gongwin Biopharm Holdings Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Gongwin Biopharm Holdings Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Gongwin Biopharm Holdings Co?

Some factors that can influence Gongwin Biopharm Holdings Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Gongwin Biopharm Holdings Co pay?

Over the past 12 months, Gongwin Biopharm Holdings Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gongwin Biopharm Holdings Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Gongwin Biopharm Holdings Co?

The current dividend yield of Gongwin Biopharm Holdings Co is .

When does Gongwin Biopharm Holdings Co pay dividends?

Gongwin Biopharm Holdings Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gongwin Biopharm Holdings Co?

Gongwin Biopharm Holdings Co paid dividends every year for the past 0 years.

What is the dividend of Gongwin Biopharm Holdings Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gongwin Biopharm Holdings Co located?

Gongwin Biopharm Holdings Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gongwin Biopharm Holdings Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gongwin Biopharm Holdings Co from 9/29/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Gongwin Biopharm Holdings Co pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Gongwin Biopharm Holdings Co in the year 2023?

In the year 2023, Gongwin Biopharm Holdings Co distributed 0 TWD as dividends.

In which currency does Gongwin Biopharm Holdings Co pay out the dividend?

The dividends of Gongwin Biopharm Holdings Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gongwin Biopharm Holdings Co

Our stock analysis for Gongwin Biopharm Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gongwin Biopharm Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.